Tectorigenin induces vasorelaxation in porcine coronary arteries through activation of Kv channels and oestrogen receptor modulation
8.4
来源：
Nature
关键字：
siRNA
发布时间：
2025-10-24 23:48
摘要：
Tectorigenin, a plant-derived isoflavone, has been shown to induce significant vasorelaxation in porcine coronary arteries, primarily through the activation of voltage-gated potassium (Kv) channels and modulation of estrogen receptors. This study highlights its potential as a novel therapeutic agent for ischemic heart disease, addressing the need for new vasoprotective strategies. The research indicates a unique pharmacological profile for tectorigenin, distinct from other isoflavones, and emphasizes the importance of further in vivo studies to explore its clinical applicability.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+重点关注领域符合度
business_impact
0.5分+商业影响力
scientific_rigor
1.5分+数据支撑的科学性
timeliness_innovation
1.5分+时效性与创新性
investment_perspective
2.5分+BOCG投资视角
market_value_relevance
1.0分+市场价值相关性
team_institution_background
0.5分+团队与机构背景
technical_barrier_competition
0.4分+技术壁垒与竞争格局
关键证据
Tectorigenin induces concentration-dependent relaxation in porcine coronary arteries.
The study provides novel insights into the cardiovascular actions of tectorigenin.
Findings suggest a distinct mechanism of action for tectorigenin compared to other isoflavones.
真实性检查
否
AI评分总结
Tectorigenin, a plant-derived isoflavone, has been shown to induce significant vasorelaxation in porcine coronary arteries, primarily through the activation of voltage-gated potassium (Kv) channels and modulation of estrogen receptors. This study highlights its potential as a novel therapeutic agent for ischemic heart disease, addressing the need for new vasoprotective strategies. The research indicates a unique pharmacological profile for tectorigenin, distinct from other isoflavones, and emphasizes the importance of further in vivo studies to explore its clinical applicability.